Multi-institutional team awarded NCI grant to open novel AML trial 6/23/2025 Multi-institutional team awarded NCI grant to open novel AML trial Full Story
Novel drug achieves high objective response rate in heavily pretreated chronic lymphocytic leukemia 6/18/2025 Novel drug achieves high objective response rate in heavily pretreated chronic lymphocytic leukemia Full Story